(MENAFN- EIN Presswire)
Solid Tumor Testing market 2025
Based on region, North America held the largest share in 2024, contributing to around two-fifths of the global solid tumor testing market share.
PORTLAND, OR, UNITED STATES, February 3, 2025 /EINPresswire / -- Solid tumor testing is a medical diagnostic procedure that involves analyzing a sample of a solid mass (tumor) taken from a patient to determine the presence and characteristics of cancerous cells. This testing can help diagnose the type of cancer and inform
treatment decisions. The sample is typically obtained through a biopsy procedure and is then examined in a laboratory using techniques such as histology, cytology, or molecular testing. The results of solid tumor testing can be used to guide the selection of appropriate cancer therapies and monitor the effectiveness of treatment.
Allied Market Research has published a study report with the title Solid Tumor Testing Market Size was Valued at USD 23.8 billion in 2021 and is Projected to Garner USD 46.7 billion by 2031, registering a CAGR of 7.0% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Get Sample PDF Report with Graphs and Figures Here:
What are the factors driving the Solid Tumor Testing Market?
Rise in government funding for sepsis-related research activities and increase in the prevalence of infectious diseases drive the growth of the global sepsis diagnostic market. On the other hand, high costs associated with automated diagnostics devices impede the growth to some extent. However, developments in rapid diagnosis/point-of-care) techniques for early sepsis diagnostics are expected to create lucrative opportunities in the industry.
Top Key Players of Solid Tumor Testing
. QIAGEN
. QUEST DIAGNOSTICS INCORPORATED
. Abbott Laboratories
. Agilent Technologies Inc.
. Biocare Medical LLC
. F. Hoffmann-La Roche AG
. ILLUMINA, INC.
. MedGenome Labs Private Ltd
. MYRIAD GENETICS, INC.
. Thermo Fisher Scientific, Inc
Solid Tumor Testing Market Segmentation: –
The research provides detailed segmentation of the global solid tumor testing market based on type, application, end-user, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.
Based on type, the genetic testing segment held the highest share in 2021, accounting for nearly two-thirds of the global solid tumor testing market, and is expected to continue its leadership status during the forecast period. Moreover, the same segment is expected to register the highest CAGR of 7.3% from 2022 to 2031.
Based on application, the melanoma segment accounted for the highest share in 2021, contributing to nearly one-fifths of the global solid tumor testing market, and is expected to maintain its lead in terms of revenue during the forecast period. However, the breast segment is expected to manifest the highest CAGR of 7.7% from 2022 to 2031.
Based on end-user, the hospital segment accounted for the highest share in 2021, holding nearly one-third of the global solid tumor testing market, and is expected to continue its leadership status during the forecast period. However, the academic research institutions segment is estimated to grow at the highest CAGR of 7.2% during the forecast period.
Based on region, North America held the largest share in 2021, contributing to around two-fifths of the global solid tumor testing market share, and is projected to maintain its dominant share in terms of revenue in 2031. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 8.3% during the forecast period. The research also analyzes regions including Europe and LAMEA.
Purchase the Report:
Our Market Research Solution Provides You Answer to Below Mentioned Question:
. Which are the driving factors responsible for the growth of market?
. Which are the roadblock factors of this market?
. What are the new opportunities, by which market will grow in coming years?
. What are the trends of this market?
. Which are main factors responsible for new product launch?
. How big is the global & regional market in terms of revenue, sales and production?
. How far will the market grow in forecast period in terms of revenue, sales and production?
. Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
. How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
. Which region has more opportunities?
By Region Outlook
. North America
(U.S., Canada, Mexico)
. Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
. Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
. LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
...
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of“Market Research Reports” and“Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
David Correa
Allied Market Research
+ + 1 800-792-5285
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN03022025003118003196ID1109159675